Comments on ''Detection of galactomannan in the bronchoalveolar lavage of high-risk patients with invasive aspergillosis admitted at the intensive care unit'' by Khodavaisy et al.

Authors

1 Acquired Immunodeficiency Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

2 Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Comments on ''Detection of galactomannan in the bronchoalveolar lavage of high-risk patients with invasive aspergillosis admitted at the intensive care unit'' by Khodavaisy et al.  AWT-SEP    AWT-SEP    AWT-SEP    AWT-SEP    AWT-SEP    AWT-SEP  Galactomannan in bronchoalveolar lavage for diagnosis of invasive aspergillosis  We read with interest the prospective study by Khodavaisy et al on” Detection of galactomannan(GM) in bronchoalveolar lavage(BAL) of the intensive care unit patients at risk for invasive aspergillosis (IA)  “.In this study authors reported that there are no available data on GM detection in BAL samples among ICU patients in the Middle East. A study that was performed in ICU patients with underlying predisposing conditions for IA between August 2010 and September 2011 that GM was measured using the Platellia Aspergillus EIA test kit. The conclusion was that the galactomannan level in BAL fluid is more sensitive for diagnosis. (1)

Keywords


Volume 1, Issue 3
September 2015
Pages 1-2
  • Receive Date: 09 July 2019
  • Revise Date: 10 October 2020
  • Accept Date: 09 July 2019
  • First Publish Date: 09 July 2019
  • Publish Date: 01 September 2015